Haemorrhages and Thromboembolic Venous Disease of the Postpartum

Hémorragies et Maladie Veineuse Thromboembolique du Post-partum : Epidémiologie, Etudes Des déterminants Cliniques et Biologiques

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02443610

Acronym

HEMOTHEPP

Enrollment

20241

Registered

2015-05-14

Start date

2015-01-06

Completion date

2021-04-27

Last updated

2023-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Hemorrhage, Venous Thromboembolism

Keywords

Postpartum Hemorrhage, Venous Thromboembolism, Pregnancy

Brief summary

The aim of this study is to evaluate the frequencey and the determinants of postpartum major complications (hemorrhage and thrombosis) up to 3 months after delivery in the maternity hospitals of Finistère (Bretagne - France)

Detailed description

This is an analytical observational prospective multicenter cohort study , conducted on all the maternity hospitals in Finistère (Bretagne - France), with a biological collection. This protocol allows to study all women at risk of PPH (Postpartum Hemorrhage) and postpartum venous thromboembolic disease, including maternity level 1-3 without case selection. The prospective nature of the study should provide a more detailed analysis of exposures in this particular population of women (risk factors related to the field, childbirth, the postpartum events ...). The events of interest were PPH and venous thromboembolic disease.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

16 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Any woman giving birth and supported in one of Gynaecology Obstetrics services of a maternity Finistere. * Women ≥ 16 at the time of the collection of non-opposition. * For minor patients: understanding the patient and at least one parent. * All births ≥ 15 weeks gestation.

Exclusion criteria

* Home Birth * Expressed opposition to participation in this study. * Childbirth under X. * Parent (s) uninformed of the pregnancy of their child.

Design outcomes

Primary

Measure	Time frame	Description
Postpartum Hemorrhage	2 days	Volume of blood loss up to 48 hours after delivery and / or weight compresses collected at delivery, and / or diagnosis of the clinician
Symptomatic thromboembolic events	3 month	—

Countries

France

Outcome results